Neogen Chemicals share news, announcements and annual reports

NSE: NEOGENBSE: 542665Chemicals & PetrochemicalsSmall Cap

Neogen Chemicals Limited · Face value ₹10 · Listed May 2019 · Issue price ₹215

₹2,171.40₹90.30 (3.99%)BSE ₹2,179.35

Share price at the NSE close on 30 Oct 2026. Previous close ₹2,261.70.

30 Oct: open ₹2,270.00, high ₹2,270.00, low ₹2,158.90

52-week range of traded prices to 30 Oct 2026

₹966.70Low, 10 Dec 2025₹2,785.00High, 14 Oct 2026

Market cap: ₹6,523 Cr856th largest listed
P/E: 161.39
P/B: 4.14
Dividend yield: 0.05%
ROE: 3.4%
ROCE: 4.4%
Debt to equity: 0.99
Volume, NSE: 77,06049.3% delivered

Neogen Chemicals board meetings

86 filed, newest first. Page 2 of 2.

Nov 2022
- 5 Nov · Board meeting
  Board Meeting held on 05-Nov-2022 to consider financial statements for the period ended September 2022
Oct 2022
- 29 Oct · Board meeting
  Board Meeting to be held on 05-Nov-2022 to consider financial statements for the period ended September 2022
Aug 2022
- 6 Aug · Board meeting
  Board Meeting held on 06-Aug-2022 to consider financial statements for the period ended June 2022
Jul 2022
- 30 Jul · Board meeting
  Board Meeting to be held on 06-Aug-2022 to consider financial statements for the period ended June 2022
- 18 Jul · Board meeting
  Board Meeting held on 18-Jul-2022 to consider Other business matters i.e. Re-appointment of Managing Director
May 2022
- 14 May · Board meeting
  Board Meeting held on 14-May-2022 to consider financial statements for the period ended March 2022 Dividend, Statement of Deviation/ Variation in utilization of funds ( Statement) as at March 31, 2022, and approved an estimated capex of upto Rs. 150 crores at Dahej SEZ Plant
- 7 May · Board meeting
  Board Meeting to be held on 14-May-2022 to consider financial statements for the period ended March 2022 and Dividend. Pursuant to regulation 29 and 33 of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, May 14, 2022, inter-alia, to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2022 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2022 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting.
Jan 2022
- 29 Jan · Board meeting
  With regards to the captioned subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, January 29, 2022 which commenced at 3.00 p.m. (IST) and concluded at 5.05 p.m. (IST), inter alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2021, pursuant to Regulation 33 of the Listing Regulations along with the Limited Review Report thereon as submitted by the Statutory Auditors of the Company and duly reviewed and recommended by the Audit Committee and the same is enclosed herewith;
- 22 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021
Dec 2021
- 8 Dec · Board meeting
  Board meeting held on December 08, 2021.
- 5 Dec · Board meeting
  To consider Fund Raising
Oct 2021
- 30 Oct · Board meeting
  Outcome of Board meeting held on October 30, 2021.
- 23 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021
Aug 2021
- 7 Aug · Board meeting
  Board meeting held on August 07, 2021.
Jul 2021
- 31 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters
May 2021
- 29 May · Board meeting
  Board meeting held on May 29, 2021.1. Approved the Audited Financial Results (Standalone and Consolidated) of the Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2021 , pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee; Pursuant to Regulation 33(3) (d) of the Listing Regulations, we would like to declare that the Statutory Auditors of the Company M/s JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021 with un-modified opinion and a declaration to that effect is enclosed.2. Recommended a final dividend of Rs. 2.25 per Equity Share for the Financial Year 2020-21, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company.3. Constitution of the Risk Management Committee of the Company.
- 22 May · Board meeting
  To consider and approve the Audited financial results for the quarter and financial year ended March 31, 2021 and dividend
Feb 2021
- 13 Feb · Board meeting
  Board meeting held on February 13, 2021.With reference to the captioned subject and pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (Listing Regulations), please be informed that the Board of Directors of the Company at its meeting held today i.e. Saturday, February 13, 2021, which commenced at 3.30 p.m. and concluded at 5.30 p.m., inter alia, considered and approved the Un-audited Financial Results (Standalone & Consolidated) of the Company along with the Limited Review Report thereon as submitted by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2020, as duly reviewed and recommended by the Audit Committee. The same is enclosed herewith.The Un-Audited Financial Results (Standalone & Consolidated) are also being made available on the Company s website i.e. www.neogenchem.com
- 6 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020
Nov 2020
- 7 Nov · Board meeting
  Outcome of Board Meeting held on November 07, 2020.With reference to the captioned subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (Listing Regulations), this is to inform you that at the meeting of the Board of Directors of the Company which commenced at 5.30 p.m. and concluded at 8.15 p.m. today i.e. Saturday, November 7, 2020, the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2020, pursuant to Regulation 33 of the Listing Regulations along with the Limited Review Report thereon as submitted by the Statutory Auditors of the Company and duly reviewed and recommended by the Audit Committee was approved by the Board. The same is enclosed herewith.
Oct 2020
- 31 Oct · Board meeting
  To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2020
- 10 Oct · Board meeting
  Board meeting held on October 10, 2020.The Board of Directors of the Company has at its Board Meeting held today i.e. Saturday, October 10, 2020 at 6.30 p.m. and concluded at 7.48 p.m. approved the appointment of Mr. Ketan Vyas as the Chief Financial Officer and Whole time Key Managerial Personnel of the Company with effect from October 10, 2020
Aug 2020
- 8 Aug · Board meeting
  Outcome of the meeting of the Board of Directors of the Company which commenced at 2.00 P.M and concluded at 7.15 P.M. today i.e. Saturday, August 8, 2020
- 1 Aug · Board meeting
  ( Listing Regulations ), notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, August 8, 2020 through video conferencing due to COVID- 19 pandemic, inter-alia, to consider, approve and take on record the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2020, along with limited review report of the Statutory Auditors thereon.
Jul 2020
- 20 Jul · Board meeting
  Board meeting held on July 20, 2020 and the following decisions were taken at the Board meeting of the Company held on Monday, 20th July 2020 at 12.00 p.m. and concluded at 01.30 PM.:1) Mr. Mahesh Tanna, Chief Financial Officer of the Company has tendered his resignation on 18th July, 2020 and the Board has accepted his resignation. Accordingly he shall cease to be the Key Managerial Personnel of the company. The Nomination and Remuneration Committee of the board is in the process of identifying and recommending candidates for filling up this vacancy caused by the resignation as per the provisions of Companies Act, 2013 and same has been noted at the Nomination and remuneration committee meeting held on 20th July 2020. Also the same will be considered and approved by the Board shortly.2) Re- Appointment of the existing internal Auditor Ms. Kshama Walavalkar, Chartered Accountant (Membership No: 172453), as an Internal Auditor of the Company to conduct the Internal Audit of the Company upto to the quarter ended 30th September, 2020 as recommended at the Audit Committee meeting held on 20th July 2020 and approved by the Board.
May 2020
- 24 May · Board meeting
  Board meeting held on May 23, 2020.the meeting of the Board of Directors of the Company which commenced at 3.00 P.M and concluded at 11.35 P.M. today i.e. May 23, 2020, the following decisions were taken:1. Approval of Audited Standalone Financial Results of the Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2020 , pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee ;2. Approval of Audited Consolidated Financial Results of the Company along with the Audit Report for the Quarter and Financial Year ended March 31, 2020 , pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee;Further as required in terms of Regulation 33(3) (d) of the Listing Regulations, we would like to confirm that the Statutory Auditors of the Company M/s JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31, 2020 with un-modified opinion.3. Recommendation of a final dividend of Rs. 2/- per Equity Share for the Financial Year 2019-20, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company.
- 18 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2020
Feb 2020
- 8 Feb · Board meeting
  Board meeting held on February 08, 2020.Outcome of Board Meeting held on Saturday, February 8, 2020.With regards to the captioned matter and pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), we enclose herewith Un-audited Financial Results (Standalone and Consolidated basis) for the quarter and nine months ended December 31, 2019, along with Limited Review Report duly submitted by the Statutory Auditors of the company which has been duly reviewed and recommended by the Audit Committee. The above unaudited financial results were approved by the Board of Directors of the Company at its meeting held today which commenced at 12:00 Noon and concluded at 6.00 P.M. Kindly take the above on your record and disseminate the same for the information of investors.
Jan 2020
- 31 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019
Nov 2019
- 12 Nov · Board meeting
  Board meeting held on November 12, 2019.
- 4 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2019
Aug 2019
- 9 Aug · Board meeting
  Board meeting held on August 09, 2019.
- 9 Aug · Board meeting
  Board meeting held on August 09, 2019.
- 1 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2019
May 2019
- 27 May · Board meeting
  Outcome of Board Meeting held on May 25, 2019.
- 17 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019

Neogen Chemicals board meetings

Nov 2022

Oct 2022

Aug 2022

Jul 2022

May 2022

Jan 2022

Dec 2021

Oct 2021

Aug 2021

Jul 2021

May 2021

Feb 2021

Nov 2020

Oct 2020

Aug 2020

Jul 2020

May 2020

Feb 2020

Jan 2020

Nov 2019

Aug 2019

May 2019